ARTICLE | Company News
FDA committee to discuss Bayer's riociguat
June 27, 2013 12:45 AM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Aug. 6 to discuss an NDA from Bayer AG (Xetra:BAYN) for Adempas riociguat to treat pulmonary arterial hypertension (PAH) and chroni...